CompletedNot Applicable

Perioperative Outcomes of Anatomic Lung Resections in Patients Who Recovered From Coronavirus Disease 2019

Philippines16 participantsStarted 2022-10-10

Plain-language summary

This study will determine the outcomes of anatomic lung resections in patients who recovered from coronavirus disease 2019 (COVID-19) disease by describing the morbidity and mortality as well as the length of postoperative hospital stay.

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * underwent anatomic lung resection * previous COVID-19 infection documented by nasopharyngeal swab RT-PCR or GeneXpert * with negative nasopharyngeal swab RT-PCR or GeneXpert prior to lung resection Exclusion Criteria: * with incomplete patient records

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Mortality rate

Timeframe: perioperative period (up to 30 days after anatomic lung resection)

Major complication rate

Timeframe: perioperative period (up to 30 days after anatomic lung resection)

Minor complication rate

Timeframe: perioperative period (within 30 days after anatomic lung resection)

Length of postoperative hospital stay

Timeframe: perioperative period (up to 30 days after anatomic lung resection)

Trial details

NCT IDNCT05513248

SponsorLung Center of the Philippines

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-10-31

View on ClinicalTrials.gov More COVID-19 trials

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Mortality rate

Timeframe: perioperative period (up to 30 days after anatomic lung resection)

Major complication rate

Timeframe: perioperative period (up to 30 days after anatomic lung resection)

Minor complication rate

Timeframe: perioperative period (within 30 days after anatomic lung resection)

Length of postoperative hospital stay

Timeframe: perioperative period (up to 30 days after anatomic lung resection)